What is AliveCor?
AliveCor, Inc. is a pioneering medical software company that empowers individuals to monitor their cardiac health remotely. Founded in 2010 and headquartered in Mountain View, California, the company is best known for its KardiaMobile devices, including the KardiaMobile 6L and the credit-card-sized KardiaMobile Card. These innovative products allow users to record medical-grade EKGs anytime, anywhere, detecting common arrhythmias. The company's commitment to accessible and proactive heart health management positions it at the forefront of the digital health revolution, integrating advanced technology with user-friendly design to improve patient outcomes and reduce healthcare burdens.
How much funding has AliveCor raised?
AliveCor has raised a total of $154.6M across 7 funding rounds:
Series A
$3.3M
Series B
$10.5M
Series C
$20M
Series D
$30M
Debt
$20M
Other Financing Round
$5.8M
Series E
$65M
Series A (2011): $3.3M with participation from Oklahoma Life Science Fund, Qualcomm Ventures, and Burrill & Co.,
Series B (2012): $10.5M led by Khosla Ventures Acquisition, Burrill & Co.,, Oklahoma Life Science Fund, and Qualcomm Ventures
Series C (2016): $20M supported by WP Global Partners
Series D (2017): $30M featuring Mayo Clinic and Omron Healthcare
Debt (2019): $20M backed by Oxford Finance
Other Financing Round (2019): $5.8M, investors not publicly disclosed
Series E (2020): $65M led by BOLD Capital Partners, OMRON Corporation, Qualcomm Ventures, WP Global Partners, and Khosla Ventures Acquisition
Key Investors in AliveCor
BOLD Capital Partners
BOLD Capital Partners is a venture capital firm dedicated to investing in entrepreneurs and technologies that aim to transform the world, focusing on emerging science and technologies that can disrupt large markets.
Qualcomm Ventures
Qualcomm Ventures is the venture capital arm of Qualcomm Incorporated, a global leader in wireless technologies, investing in companies that leverage mobile and connectivity innovations.
Mayo Clinic
Mayo Clinic is a nonprofit global healthcare organization renowned for its integrated clinical practice, education, and medical research, contributing to advancements in patient care and medical innovation.
What's next for AliveCor?
The recent major strategic investment in AliveCor signals a strong confidence from its backers in the company's future trajectory. This capital infusion is likely to fuel further research and development into advanced cardiac monitoring technologies, potentially expanding the company's product portfolio and enhancing its existing offerings. Furthermore, the funding may support AliveCor's efforts to broaden its market reach, both domestically and internationally, and to forge new strategic partnerships within the healthcare ecosystem. The company's focus on innovation and its established position in the remote patient monitoring market suggest a continued path of growth and influence in shaping the future of cardiovascular care.
See full AliveCor company page
